+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Randomized, controlled trial split-faced study of 595-nm pulsed dye laser in the treatment of acne vulgaris and acne erythema in adolescents and early adulthood

Randomized, controlled trial split-faced study of 595-nm pulsed dye laser in the treatment of acne vulgaris and acne erythema in adolescents and early adulthood

International Journal of Dermatology 56(8): 884-888

The high prevalence of acne vulgaris in teenagers has increased comorbidities. Lasers offer alternative options for acne treatment because they have rapid action, low systemic adverse effects, and do not require everyday treatment. To study the efficacy and patients' satisfaction of 595-nm pulse dye laser (PDL) treatment of acne vulgaris and acne erythema in adolescents and early adulthood, we designed a blocked-randomized, split-faced 595-nm PDL (fluence 8 J/cm3 pulse duration 10 ms, spot size 7 mm, 2 session every 2 weeks) study in patients with mild to moderate acne by comparing the laser-treated and non-treated side. The acne lesion counts, acne erythema grading, and acne severity grading were evaluated at baseline and 2, 4, and 8 weeks. Thirty patients were recruited. The results showed no statistically significant difference except the papule count at week 4 which was -1.828 on the treated side and 0.103 on the non-treated side of the face, P-value 0.0018. There was no statistically significant difference of acne severity grading and acne erythema grading between both sides of the face. The mean scores of patients' satisfaction on the laser-treated side were 75, 81, and 81%, respectively. The PDL treatment in this study reveals no significant improvement in acne therapy; however, the patients were satisfied with this laser treatment.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 060168394

Download citation: RISBibTeXText

PMID: 28447362

DOI: 10.1111/ijd.13631

Related references

Treatment of Acne Vulgaris With Salicylic Acid Chemical Peel and Pulsed Dye Laser: A Split Face, Rater-Blinded, Randomized Controlled Trial. Journal of Lasers in Medical Sciences 6(4): 167-170, 2015

Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial. JAMA 291(23): 2834-2839, 2004

A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris. Journal of the American Academy of Dermatology 56(3): 432-438, 2007

The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial. British Journal of Dermatology 163(2): 395-401, 2010

Photodynamic therapy for acne vulgaris: a randomized, controlled, split-face clinical trial of topical aminolevulinic acid and pulsed dye laser therapy. Journal of Cosmetic Dermatology 9(1): 28-34, 2010

Intense pulsed light vs. pulsed-dye laser in the treatment of facial acne: a randomized split-face trial. Journal of the European Academy of Dermatology and Venereology 24(7): 773-780, 2010

Comparison of fractional, nonablative, 1550-nm laser and 595-nm pulsed dye laser for the treatment of facial erythema resulting from acne: a split-face, evaluator-blinded, randomized pilot study. Journal of Cosmetic and Laser Therapy 16(3): 120-123, 2014

Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial. Journal of the American Academy of Dermatology 58(3): 387-394, 2008

Pulsed-dye laser treatment for inflammatory acne vulgaris: Randomised controlled trial. Lancet (North American Edition) 362(9393): 1347-1352, 2003

Concomitant Use of 1,550-nm Nonablative Fractional Laser With Low-Dose Isotretinoin for the Treatment of Acne Vulgaris in Asian Patients: A Randomized Split-Face Controlled Study. Dermatologic Surgery 44(9): 1201-1208, 2018

Randomized split-face controlled study to evaluate 1550-nm fractionated erbium glass laser for treatment of acne vulgaris--an image analysis evaluation. Dermatologic Surgery 40(11): 1191-1200, 2014

Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis 68(4 Suppl): 20-24, 2001

NLite pulsed dye laser therapy for acne vulgaris a randomized clinical trial. Journal of Investigative Dermatology 122(3): A51, 2004

Safety of non-ablative fractional laser for acne scars within 1 month after treatment with oral isotretinoin: A randomized split-face controlled trial. Lasers in Surgery and Medicine 49(10): 886-890, 2017

Comparison of a 585-nm pulsed dye laser and a 1064-nm Nd:YAG laser for the treatment of acne scars: A randomized split-face clinical study. Yearbook of Dermatology and Dermatologic Surgery 2010: 460-461, 2010